QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
Clinical trial NCT01834235 · TERMINATED
Trial details
- NCT number
- NCT01834235
- Sponsor
- Precision Biologics, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-03-13
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.